We’re thrilled to announce that the Rx Save Card has successfully raised a seed investment round led by Distributed Ventures, with participation from other key industry insiders! This exciting news has already been featured in several publications, including Business Wire and Yahoo Finance. This funding will fuel our mission to transform the prescription drug landscape and empower employers and employees to save significantly on medication costs.
Our Mission: Choice and Savings
At the Rx Save Card, we believe in giving consumers the power to choose the most affordable option for their prescriptions. We’ve built a platform that provides access to lower drug prices, including those offered by Mark Cuban Cost Plus Drug Company, without requiring employers to change their existing PBMs. This unique approach allows everyone to win – employers save money, employees avoid out-of-pocket costs, and everyone gets the medications they need.
Partnering with Distributed Ventures
We’re particularly excited to partner with Distributed Ventures, a fund with deep expertise in the employee benefits space. Their Managing Partner, Shawn Ellis, has been an invaluable advisor from the earliest stages of the Rx Save Card, offering guidance and support every step of the way. We’re confident that this partnership will help us accelerate our growth and expand our impact.
Positive Momentum
Since our official launch in July 2024, we’ve received overwhelmingly positive feedback from pharmacy benefits consultants and employee benefits brokers. We’re already onboarding employer customers, and this new capital will enable us to enhance our solution with even more ways for employers and employees to save on prescription drugs.
Looking Ahead
This seed investment marks a significant milestone in our journey to make healthcare more affordable and accessible. We’re grateful for the support of our investors and partners, and we’re more committed than ever to delivering on our promise of empowering consumers and driving down prescription drug costs.